338 filings
Page 4 of 17
8-K
mbgxtehif99y60b7fc3b
9 Dec 21
Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B
8:15am
8-K
o45eb0 sh5pk49
7 Dec 21
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021
8:02am
8-K
ruflk5i251ons6qepi8
19 Nov 21
Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management
9:17am
SC TO-T/A
k66v uere
19 Nov 21
Third party tender offer statement (amended)
9:01am
SC TO-T/A
1cate5qkzoufs1 gkga
18 Nov 21
Third party tender offer statement (amended)
6:02am
SC TO-T/A
hd0lew4zmag649rmo4
12 Nov 21
Third party tender offer statement (amended)
6:05am
8-K
hjnhodk
9 Nov 21
Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021
8:01am
8-K
knrlz opv1y1kp9j
3 Nov 21
Pacira BioSciences Reports Third Quarter 2021 Financial Results
8:04am
SC TO-T/A
igfr5gljb33g39ii
1 Nov 21
Third party tender offer statement (amended)
4:46pm
SC TO-T
tso85p4gp4t7xk7
22 Oct 21
Third party tender offer statement
6:03am
SC TO-C
nki73es
12 Oct 21
Information about tender offer
6:08am
8-K
h0kwh8vz0ua1c
12 Oct 21
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
6:06am
8-K
ifr8k0 sab2spsgnvp8
15 Sep 21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021
7:31am
8-K
7s22ot
10 Aug 21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021
8:02am
S-8
727k7i 9v
3 Aug 21
Registration of securities for employees
4:31pm
8-K
mz8mnkcmt6 sff74ts
3 Aug 21
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
8:02am
8-K
25wd3op
13 Jul 21
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
8:02am
8-K
p1g6e7r
17 Jun 21
Departure of Directors or Certain Officers
4:30pm